[FOR RELEASE August 28, 2018 China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman BEIJING, China — August 28, 2018 — “We deeply regret that Mr. David Gao, acting individually in his personal capacity, has attempted to challenge the completion of the private placement that was]
[FOR RELEASE August 28, 2018 China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman BEIJING, China — August 28, 2018 — “We deeply regret that Mr. David Gao, acting individually in his personal capacity, has attempted to challenge the completion of the private placement that was]
[EXECUTION VERSION SHARE PURCHASE AGREEMENT by and among CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. BEACHHEAD HOLDINGS LIMITED and DOUBLE DOUBLE HOLDINGS LIMITED Dated as of August 24, 2018 TABLE OF CONTENTS Article I DEFINITIONS 1 Section 1.01. Defined Terms 1 Section 1.02. Interpretation and Rules of C]
[EXECUTION VERSION SHARE PURCHASE AGREEMENT by and among CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. BEACHHEAD HOLDINGS LIMITED and DOUBLE DOUBLE HOLDINGS LIMITED Dated as of August 24, 2018 TABLE OF CONTENTS Article I DEFINITIONS 1 Section 1.01. Defined Terms 1 Section 1.02. Interpretation and Rules of C]
[EXECUTION VERSION SHARE PURCHASE AGREEMENT by and between CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. and CITIC CAPITAL MB INVESTMENT LIMITED Dated as of August 24, 2018 TABLE OF CONTENTS Article I DEFINITIONS 1 Section 1.01. Defined Terms. 1 Section 1.02. Interpretation and Rules of Construction 6 Artic]
[FOR RELEASE August 24, 2018 China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement BEIJING, China — August 24, 2018 — After careful review of the Consortium’s proposal, the Board has unanimously determined that it is not in the best interests of the Com]
[FOR RELEASE August 24, 2018 China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement BEIJING, China — August 24, 2018 — After careful review of the Consortium’s proposal, the Board has unanimously determined that it is not in the best interests of the Com]
[FOR RELEASE August 21, 2018 China Biologic Announces Receipt of Competing Non-Binding Acquisition Proposal BEIJING, China — August 21, 2018 — About China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc. (NASDAQ: CBPO) is a leading fully integrated plasma-based biopharmaceutica]
